about
Genetic control of the innate immune responseTowards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnectUrsolic acid isolated from guava leaves inhibits inflammatory mediators and reactive oxygen species in LPS-stimulated macrophages.Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.Effect of hyperbaric oxygen and ulinastatin on plasma endotoxin, soluble CD14, endotoxin-neutralizing capacity and cytokines in acute necrotizing pancreatitis.The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.Polymyxin B hemoperfusion: a mechanistic perspective.Modulation of systemic inflammatory response after cardiac surgery.Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated RatsPurinergic Signaling and the Immune Response in Sepsis: A ReviewPolymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry.Intestinal ischemia/reperfusion injury: defining the role of the gut microbiome.Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders.The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial.Déjà-vu from the nineties: is there a perspective for anti-endotoxin strategies to improve the outcome of multiple trauma patients?Stimulation and suppression of innate immune function by American ginseng polysaccharides: biological relevance and identification of bioactives.Airborne Asian sand dust enhances murine lung eosinophilia.Lipopolysaccharide-trap-Fc, a multifunctional agent to battle gram-negative bacteria.Mechanisms of human complement factor B induction in sepsis and inhibition by activated protein C.
P2860
Q24800607-6C696780-0613-4CE0-A6FA-A93EBACE0687Q26996658-8AA45E89-351A-419C-A759-EB961833B4D4Q30907742-1B2555DE-2015-4876-A320-0B8FD8F38C4DQ33776933-E26ED98F-0F85-41D9-A088-2C868627F432Q34028000-606B13F8-CAE9-4FD8-8E80-A0C622D61DF5Q34053131-138998A1-3C73-4E2A-BD1E-CECA0882A5F8Q34429986-DD7617A9-64D9-4348-BF0E-08D565ED477FQ36320195-5FCF40A7-AB8D-4EFD-8C63-0116D480F5E7Q36328053-E89C6CC6-D644-4E0E-B68B-E27C89535533Q36447185-5EFD0D9B-50D6-4920-8F7B-57C9A21C143BQ36923670-1A375533-D001-489B-A803-FA1D1693D17FQ37159148-16EFE45D-7FC8-4E36-8DD0-5936911869F6Q37755158-4A5EFB95-8909-4088-8881-07017DDBD3A0Q38032610-2D9F40AD-4C43-43B2-B820-1B93904DA652Q38428613-EB0A8C53-DD8A-4606-96F7-5233C6B464CDQ38821981-124A8779-FD38-4D1D-8B35-8E7D93D4E40CQ38957695-ECD8D34E-AD64-4045-A575-B6E748D315CFQ39654660-68930847-0E26-47FE-8E48-55B70FE8FAC9Q39852946-E608D8ED-9458-47E8-AB68-3365ABB4360DQ51772993-EC93BBB0-A9B6-4835-832F-3F27028EEC34
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Endotoxin as a drug target.
@ast
Endotoxin as a drug target.
@en
type
label
Endotoxin as a drug target.
@ast
Endotoxin as a drug target.
@en
prefLabel
Endotoxin as a drug target.
@ast
Endotoxin as a drug target.
@en
P1476
Endotoxin as a drug target.
@en
P2093
Steven M Opal
Thomas Glück
P304
P356
10.1097/00003246-200301001-00009
P407
P433
P577
2003-01-01T00:00:00Z